BeStock  
Stocks › Medical Devices › DCTH

Delcath Systems DCTH

US equityMarket cap rank #3435Medical Devices
$18.79 −$0.45 (-2.34%)
Market closed · Nov 20, 8:10 pm ET · Last extended-hours $18.50 -1.54%
Open$18.89
Prev close$19.24
Day range$18.51 – $19.35
Volume592.1K
Market cap$653.67M
P/E (TTM)117.4
Dividend yield–

Earnings

Average move on report day±10.4%last 16 reports
Closed higher7 of 1644% of the time
Best reaction+35.8%
Worst reaction-24.5%

Stock move on the day after each report

-1.1%2023/Q4+30.9%2024/Q1-4.9%2024/Q2+1.1%2024/Q3-1.6%2024/Q4+23.6%2025/Q1+1.1%2025/Q2-4.6%2025/Q3-11.9%2025/Q4-0.2%2026/Q1+22.5%2026/Q2+35.8%2026/Q3
QuarterReport dateTimingImplied moveActual moveVersus implied
2026/Q39 Nov 2026Pre Market±15.4%+35.77%Bigger than priced
2026/Q26 Aug 2026Pre Market±22.6%+22.49%Within range
2026/Q17 May 2026Pre Market±13.5%-0.18%Within range
2025/Q426 Feb 2026Pre Market±18.1%-11.85%Within range
2025/Q34 Nov 2025Pre Market±15.4%-4.62%Within range
2025/Q26 Aug 2025Pre Market±24.6%+1.14%Within range
2025/Q18 May 2025Pre Market±20.9%+23.64%Bigger than priced
2024/Q46 Mar 2025None±22.1%-1.56%Within range
2024/Q38 Nov 2024Pre Market±24.0%+1.10%Within range
2024/Q25 Aug 2024After Market±29.6%-4.93%Within range
2024/Q114 May 2024Pre Market±26.8%+30.93%Bigger than priced
2023/Q426 Mar 2024Pre Market±30.5%-1.07%Within range
2023/Q313 Nov 2023After Market±20.1%-24.50%Bigger than priced
2023/Q27 Aug 2023None±59.6%+0.25%Within range
2023/Q112 May 2023Pre Market±46.0%-0.75%Within range
2022/Q427 Mar 2023After Market±46.3%-1.33%Within range

"Implied move" is the size of move the options market was pricing ahead of the report. Move is the stock’s change on the first session after the release.

Where the revenue comes from

Quarter 2026/Q3

By business line

  • Hepzato Kit$32.68M 93.1%
  • Chemosat$2.43M 6.9%

Latest reported quarter: Q3, ended Sep 2026

Revenue$35.10M+70.7% YoY
Operating profit$7.12M+1,934.0% YoY
Net profit$6.95M+737.6% YoY
Diluted EPS$0.17+750.0% YoY
Free cash flow$6.92M+60.4% YoY
Operating cash flow$8.18M

Revenue, last 8 quarters

$15.1MDec '24$19.8MMar '25$24.2MJun '25$20.6MSep '25$20.7MDec '25$25.0MMar '26$29.1MJun '26$35.1MSep '26

Net profit, last 8 quarters

$-3.4MDec '24$1.1MMar '25$2.7MJun '25$830.0KSep '25$-1.9MDec '25$-1.1MMar '26$2.7MJun '26$7.0MSep '26

Profitability & balance sheet

Gross margin87.6%
Operating margin5.2%
Net margin6.1%
Return on equity5.4%
Return on assets4.9%
Return on invested capital5.3%
Current ratio10.87
Liabilities / assets10.4%
Cash & investments$104.32M
Total debt$2.21M
Net cash (debt)$102.10M
Free cash flow / sales18.3%

Discussion

No comments yet — be the first to weigh in on DCTH.

Sign in to join the discussion.

Scroll to Top